PR Newswire Clinical TrialsOriginal article
Roche expands cyclospora testing portfolio to support U.S. public health response
Cyclospora PCR testsPositive
AI Analysis
Summary
Roche has launched two new real-time PCR tests to detect cyclospora infection, expanding its diagnostic portfolio to support laboratory needs and U.S. public health response.
Importance:3/10
Sentiment:
0.30
diagnosticscyclosporaPCR testingpublic healthproduct launch
Related Companies
Read the original article
Published by PR Newswire Clinical Trials on August 6, 2026 12:30 PM